DJ AstraZeneca PLC ADR Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ shed 0.77% to $75.76 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.19% to 16,349.25 and the Dow Jones Industrial Average rising 0.46% to 38,852.27.
AstraZeneca PLC ADR closed $1.04 below its 52-week high ($76.80), which the company achieved on May 1st.
The ADR underperformed when compared to some of its competitors Monday, as Eli Lilly & Co. $(LLY)$ rose 4.31% to $766.68, Biogen Inc. $(BIIB)$ rose 1.80% to $221.42, and Johnson & Johnson $(JNJ)$ fell 0.46% to $148.58.
Trading volume (5.4 M) remained 151,792 below its 50-day average volume of 5.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 6, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 06, 2024 17:26 ET (21:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments